Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Leukemia/Lymphoma/Myeloma (Poster Session)

  • You have access
    Whole Body MRI and FDG PET in Myeloma
    Liza Lindenberg, Esther Mena, Anita Ton, Baris Turkbey, Elizabeth Hill, Philip Eclarinal, Dagane Daar, Hoa Tieu, Christopher Leyson, Mona Lisa Cedo, Juanita Weaver, Yolanda McKinney, Alexander Dew, Raul Braylan, Hao-Wei Wang, Constance Yuan, Irina Maric, Maryalice Stetler-Stevenson, Katherine Calvo, Alina Dulau-Florea, Peter Choyke and Dickran Kazandjian
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1327;
  • You have access
    FDG PET/CT in diagnostic evaluation and response assessment of Acute myeloid leukemia with chloroma
    Nalli Harish, Sameer Bakhshi, Anshul Sharma, Ravikant Gupta, Akshima Sharma, Sreedharan Arunraj, Rakesh Kumar and Chandrasekhar Bal
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1323;
  • You have access
    A case series of multiple myeloma PET/MR scans.
    Bridget Kistner, Stephane Desouches and Daniel Bucklan
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1324;
  • You have access
    Baseline PET/CT radiomic analysis in the prediction of refractory or relapsed diffuse large B cell lymphoma
    Hebei Li, Qian Wang and Yunyun Zhao
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1326;
  • You have access
    Role of 18F-FDG PET/CT imaging for evaluation of diagnosed or clinically suspected post-transplant lymphoproliferative disorders: a tertiary care center experience.
    Bhagwant Mittal, Rajender Kumar, Swayamjeet Satapathy, Harmandeep Singh and Anish Bhattacharya
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1321;
  • You have access
    Can FDG PET/CT replace Bone densitometry (DXA) for detection of bone loss in adult lymphoma patients?
    Rachel Bar-Shalom, Re'em Shemmer, Yonatatn Turner, Michal Amit-Kohn, Roee Steiner, Ari Zimran and Rosa Ruchlemer
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1322;
  • You have access
    Value of 18F-FDG PET/CT in the differential diagnosis of AOSD and DLBCL
    Min Zhang, Yuting Gao and Biao Li
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1325;
SNMMI

© 2025 SNMMI

Powered by HighWire